Shedding of pandemic (H1N1) 2009 virus among health care personnel, Seattle, Washington, USA

Emerging Infectious Diseases

Volumn 17, Issue 4, 2011, Pages 639-644

  Kay, Meagan ^a,b   Zerr, Danielle M ^c   Englund, Janet A ^c   Cadwell, Betsy L ^a   Kuypers, Jane ^d   Swenson, Paul ^b   Kwan Gett, Tao Sheng ^b,d   Bell, Shaquita L ^c   Duchin, Jeffrey S ^b,d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADULT; ARTICLE; BODY TEMPERATURE MONITORING; CHILL; CLINICAL ARTICLE; CLINICAL FEATURE; COUGHING; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE TRANSMISSION; FEMALE; FEVER; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MALE; MYALGIA; OCCUPATIONAL EXPOSURE; PANDEMIC INFLUENZA; QUESTIONNAIRE; SORE THROAT; SURVIVAL RATE; UNITED STATES; VIRUS DETECTION; VIRUS LOAD; VIRUS SHEDDING; VOMITING;

ADULT; ANTIVIRAL AGENTS; HEALTH PERSONNEL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; RNA, VIRAL; SURVIVAL ANALYSIS; VIRUS SHEDDING; WASHINGTON;

EID: 79953676859     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1704.100866     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel [cited 2010 Dec 21]. http://www.cdc.gov/h1n1flu/guidelines_infection_control.htm
2. Witkop CT, Duffy MR, Macias EM, Gibbons TF, Escobar JD, Burwell KN, et al. Novel influenza A (H1N1) outbreak at the U.S. Air Force Academy: epidemiology and viral shedding duration. Am J Prev Med. 2010;38:121-6. DOI: 10.1016/j.amepre.2009.10.005
3. To KK, Chan KH, Li IW, Tsang TY, Tse H, Chan JF, et al. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol. 2010;82:1-7. DOI: 10.1002/jmv.21664
4. Suess T, Buchholz U, Dupke S, Grunow R, an der Heiden M, Heider A, et al. Shedding and transmission of novel influenza A/ H1N1 infection in households, Germany, 2009. Am J Epidemiol. 2010;171:1157-64. DOI: 10.1093/aje/kwq071
5. Kuypers J, Wright N, Farrengerg J, Huang ML, Cent A, Corey L, et al. Comparison of real-time PCR assays with fl uorescent-antibody assays for diagnosis of respiratory infections in children. J Clin Microbiol. 2006;44:2382-8. DOI: 10.1128/JCM.00216-06
6. Barenfanger J, Drake C, Mueller T, Troutt T, O'Brien J, Guttman K. R-mix cells are faster, at least as sensitive and marginally more costly than conventional cell lines for the detection of respiratory viruses. J Clin Virol. 2001;22:101-10. DOI: 10.1016/S1386-6532(01)00171-8
7. Cantor AB. SAS survival analysis techniques for medical research. 2nd ed. Cary (NC): SAS Institute Inc.; 2003.
8. Centers for Disease Control and Prevention. Introduction and transmission of 2009 pandemic influenza A (H1N1) virus-Kenya, June-July 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1143-6.
9. Han K, Zhu X, He F, Liu L, Zhang L, Ma H, et al. Lack of airborne transmission during outbreak of pandemic (H1N1) 2009 among tour group members, China, June 2009. Emerg Infect Dis. 2009;15:1578-81.
10. Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, Kent CK, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med. 2009;361:2619-27. DOI: 10.1056/NEJMoa0905498
11. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775-85. DOI: 10.1093/aje/kwm375
12. Lau LL, Cowling BJ, Fang VJ, Chan KH, Lau EH, Lipsitch M, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis. 2010;201:1509-16. DOI: 10.1086/652241
13. Kaiser L, Briones MS, Hayden FG. Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection. J Clin Virol. 1999;14:191-7. DOI: 10.1016/S1386-6532(99)00058-X
14. Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DK, Cheng CK, et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis. 2010;50:707-14. DOI: 10.1086/650458
15. Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA. 1999;282:1240-6. DOI:10.1001/jama.282.13.1240
16. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-15. DOI: 10.1056/NEJMoa0903810
17. Crum-Cianfl one NF, Blair PJ, Faix D, Arnold J, Echols S, Sherman SS, et al. Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military benefi ciaries. Clin Infect Dis. 2009;49:1801-10. DOI:10.1086/648508
18. Tsalik EL, Hendershot EF, Sangvai DG, Cunningham HM, Cunningham CK, Lopez-Marti MG, et al. Clinical presentation and response to treatment of novel influenza A H1N1 in a universitybased summer camp population. J Clin Virol. 2010;47:286-8. DOI:10.1016/j.jcv.2009.12.012
19. Cutler J, Schleihauf E, Hatchette TF, Billard B, Watson-Creed G, Davidson R, et al. Investigation of the fi rst cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ. 2009;181:159-63. DOI: 10.1503/cmaj.090859
20. Ciblak MA, Albayrak N, Odabas Y, Basak Altas A, Kantuvardar M, Hasoksuz M, et al. Cases of influenza A (H1N1)v reported in Turkey, May-July 2009. Eurosurveillance. 2009;14:1-4.
21. Hayden FG, Fritz RS, Lobo MC, Alvord WG, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. J Clin Invest. 1998;101:643-9. DOI:10.1172/JCI1355